Acute lymphoblastic leukemia complicated with cerebral venous thrombosis in 14 children
10.3760/cma.j.cn112140-20200203-00058
- VernacularTitle:儿童急性淋巴细胞白血病合并脑静脉血栓形成14例诊治分析
- Author:
Tinghua LIU
1
;
Xinyu LI
;
Xiawei HAN
;
Yating ZHANG
;
Dunhua ZHOU
;
Lühong XU
;
Jingwen HUANG
;
Jianpei FANG
Author Information
1. 中山大学孙逸仙纪念医院儿科，广州 510120
- Keywords:
Leukemia;
Child;
Venous thrombosis;
Cerebral veins
- From:
Chinese Journal of Pediatrics
2020;58(9):764-768
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical characteristics and management of childhood acute lymphoblastic leukemia (ALL) complicated with cerebral venous thrombosis (CVT).Methods:The clinical data of 14 ALL children complicated with CVT who were admitted to Department of Pediatrics of Sun Yat-sen Memorial Hospital and underwent chemotherapy from January 2011 to October 2019 were collected retrospectively. The clinical manifestations, coagulation function, imaging findings, treatment plan and prognosis of patients were analyzed.Results:CVT was diagnosed in 14 (2.8%, 14/505) cases, with a median age of 10 (3-14) years at onset, 11 cases occurred in the stage of induction remission, and the acute onsets were mainly characterized by convulsions (9 cases), consciousness disorders (6 cases) and headache (4 cases). Coagulation function test showed that, before the CVT, antithrombin Ⅲ activity was lower than 60% in 8 cases, D-dimer elevated on the day of onset in 8 cases. Arteriovenous angiography showed filling defects in single (9 cases) or multiple (5 cases) venous sinuses. The most common site of venous sinus enlargement was superior sagittal sinus (10 cases). Secondary cerebral hemorrhage was found in 5 cases. Anticoagulation therapy included combination of low-molecular-weight heparin (LMWH) and warfarin in 9 cases, sequential application of LMWH and warfarin in 2 cases, and LMWH alone in 3 cases. Patients accepted further asparaginase and no CVT recurrence or progression was found.Conclusions:The secondary coagulation dysfunction during induction remission chemotherapy is the major risk factor for CVT in ALL, which needs active monitoring and early prevention. Arteriovenous angiography can diagnose accurately, and the prognosis of anticoagulant therapy with LMWH and warfarin is optimistic.
